Literature DB >> 27939431

Crosstalk between different family members: IL27 recapitulates IFNγ responses in HCC cells, but is inhibited by IL6-type cytokines.

Catherine Rolvering1, Andreas D Zimmer2, Ines Kozar3, Heike M Hermanns4, Elisabeth Letellier5, Laurent Vallar6, Petr V Nazarov7, Nathalie Nicot8, Aurélien Ginolhac9, Serge Haan10, Iris Behrmann11, Claude Haan12.   

Abstract

Interleukin-27 (IL27) is a type-I-cytokine of the IL6/IL12 family predominantly secreted by activated macrophages and dendritic cells. In the liver, IL27 expression was observed to be upregulated in patients with hepatitis B, and sera of hepatocellular carcinoma (HCC) patients contain significantly elevated levels of IL27 compared to healthy controls or patients with hepatitis and/or liver cirrhosis. In this study, we show that IL27 induces STAT1 and STAT3 phosphorylation in 5 HCC lines and 3 different types of non-transformed liver cells. We were especially interested in the relevance of the IL27-induced STAT3 activation in liver cells. Thus, we compared the IL27 responses with those induced by IFNγ (STAT1-dominated response) or IL6-type cytokines (IL6, hyper-IL6 (hy-IL6) or OSM) (STAT3-dominated response) by microarray analysis and find that in HCC cells, IL27 induces an IFNγ-like, STAT1-dependent transcriptional response, but we do not find an effective STAT3-dependent response. Validation experiments corroborate the finding from the microarray evaluation. Interestingly, the availability of STAT1 seems critical in the shaping of the IL27 response, as the siRNA knock-down of STAT1 revealed the ability of IL27 to induce the acute-phase protein γ-fibrinogen, a typical IL6 family characteristic. Moreover, we describe a crosstalk between the signaling of IL6-type cytokines and IL27: responses to the gp130-engaging cytokine IL27 (but not those to IFNs) can be inhibited by IL6-type cytokine pre-stimulation, likely by a SOCS3-mediated mechanism. Thus, IL27 recapitulates IFNγ responses in liver cells, but differs from IFNγ by its sensitivity to SOCS3 inhibition.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; IFNγ; IL27; IL6-type cytokines; SOCS3; STAT transcription factors

Mesh:

Substances:

Year:  2016        PMID: 27939431     DOI: 10.1016/j.bbamcr.2016.12.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  10 in total

1.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

Review 2.  The role of IL-6 in host defence against infections: immunobiology and clinical implications.

Authors:  Stefan Rose-John; Kevin Winthrop; Leonard Calabrese
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

Review 3.  Antiviral Activities of Interleukin-27: A Partner for Interferons?

Authors:  Heather Amsden; Olena Kourko; Madison Roth; Katrina Gee
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 4.  Dual Roles of IL-27 in Cancer Biology and Immunotherapy.

Authors:  Marina Fabbi; Grazia Carbotti; Silvano Ferrini
Journal:  Mediators Inflamm       Date:  2017-02-01       Impact factor: 4.711

5.  IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.

Authors:  Grazia Carbotti; Amin Reza Nikpoor; Paola Vacca; Rosaria Gangemi; Chiara Giordano; Francesco Campelli; Silvano Ferrini; Marina Fabbi
Journal:  J Exp Clin Cancer Res       Date:  2017-10-11

6.  Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3.

Authors:  Florence A Servais; Mélanie Kirchmeyer; Matthias Hamdorf; Nadège W E Minoungou; Stefan Rose-John; Stephanie Kreis; Claude Haan; Iris Behrmann
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-02

Review 7.  IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.

Authors:  Olena Kourko; Kyle Seaver; Natalya Odoardi; Sameh Basta; Katrina Gee
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

Review 8.  Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.

Authors:  Juliane Lokau; Victor Schoeder; Johannes Haybaeck; Christoph Garbers
Journal:  Cancers (Basel)       Date:  2019-11-01       Impact factor: 6.639

9.  Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development.

Authors:  Jiantao Fu; Feng Chen; Yuanji Lin; Jin Gao; Anna Chen; Jin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-29       Impact factor: 4.322

Review 10.  The two facets of gp130 signalling in liver tumorigenesis.

Authors:  Dirk Schmidt-Arras; Eithan Galun; Stefan Rose-John
Journal:  Semin Immunopathol       Date:  2021-05-28       Impact factor: 9.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.